Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Holding TSE:KNE?
Track your performance easily
KNE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.06 - C$0.17
Previous CloseC$0.12
Volume12.00K
Average Volume (3M)141.29K
Market Cap
C$14.58M
Enterprise ValueC$14.50M
Total Cash (Recent Filing)C$1.01M
Total Debt (Recent Filing)C$928.88K
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding131,844,567
10 Day Avg. Volume75,311
30 Day Avg. Volume141,293
Standard Deviation0.13
R-Squared0.04
Alpha0.00338
Financial Highlights & Ratios
Price to Book (P/B)-11.50
Price to Sales (P/S)97.35
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kane Biotech News
PremiumCompany Announcements
Kane Biotech to Announce Q3 Financial Results
PremiumCompany Announcements
Kane Biotech Expands with FB Dermatology Acquisition
PremiumCompany Announcements
Kane Biotech Expands with FB Dermatology Acquisition
PremiumCompany Announcements
Kane Biotech Expands with New Distribution Deal
PremiumCompany Announcements
Kane Biotech Initiates Global Wound Care Collaboration
PremiumCompany Announcements
Kane Biotech to Showcase Wound Care Innovations
PremiumCompany Announcements
Kane Biotech Bolsters Capital with Warrant ExercisePremiumCompany Announcements
Kane Biotech Reports Strong Q2 with Major GainsOptions Prices
Currently, No data available
---
Ownership Overview
KNE FAQ
What was Kane Biotech Inc’s price range in the past 12 months?
Kane Biotech Inc lowest stock price was C$0.06 and its highest was C$0.17 in the past 12 months.
What is Kane Biotech Inc’s market cap?
Currently, no data Available
When is Kane Biotech Inc’s upcoming earnings report date?
Kane Biotech Inc’s upcoming earnings report date is Apr 01, 2025 which is in 130 days.
How were Kane Biotech Inc’s earnings last quarter?
Currently, no data Available
Is Kane Biotech Inc overvalued?
According to Wall Street analysts Kane Biotech Inc’s price is currently Overvalued.
Does Kane Biotech Inc pay dividends?
Kane Biotech Inc does not currently pay dividends.
What is Kane Biotech Inc’s EPS estimate?
Kane Biotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kane Biotech Inc have?
Kane Biotech Inc has 132,511,570 shares outstanding.
What happened to Kane Biotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kane Biotech Inc?
Currently, no hedge funds are holding shares in TSE:KNE
---
Kane Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
109.09%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-27.02%
Trailing 12-Months
Company Description
Kane Biotech Inc
Kane Biotech Inc is a Canada based biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company's human health product is DispersinB and animal health products include bluestem oral care, STRIX NB, and Alosera. In addition, the company also provides technologies for industrial applications such as medical device coating and hard surface disinfectant.
---
Technical Analysis
---